Literature DB >> 29168067

Continued Transmission of HIV Among Young Adults Who Inject Drugs in San Francisco: Still Room for Improvement.

Ali Mirzazadeh1, Jennifer L Evans2, Judith A Hahn2,3, Jennifer Jain4, Alya Briceno2, Stephen Shiboski5, Paula J Lum3, Christopher Bentsen6, Geoff Davis6, Kathy Shriver6, Melanie Dimapasoc7, Mars Stone7, Michael P Busch7,8, Kimberly Page9.   

Abstract

We measured HIV incidence rate, trend and risk factors in 564 HIV-negative young people (< 30 years) who inject drugs (PWID) in San Francisco between 2000 and 2014. HIV incidence was 0.93/100 person-years (PY; 95% CI 0.50, 1.73). Incidence varied between 0.62/100 PY in 2000-2002 and 1.06/100 PY in 2012-2014 (P for trend = 1.0). HIV incidence varied significantly (P < 0.01) by race/ethnicity: among Hispanics it was 8.19/100 PY (95% CI 3.41, 19.68), African-Americans 4.59/100 PY (95% CI 1.15, 18.37), and Whites 0.26/100 PY (95% CI 0.06, 1.03). Male participants who reported sex with men (MSM) had higher HIV incidence (2.63/100 PY; 95% CI 1.31, 5.25) compared to males who did not report MSM (0.50/100 PY; 95% CI 0.12, 1.99) (P = 0.01). Despite an overall stable HIV incidence trend, incidence was elevated among African-American and Hispanic PWID, and men who have sex with men. Addressing prevention needs in these key populations is critical for the goal of eliminating HIV transmission.

Entities:  

Keywords:  Cohort studies; Drug users; Epidemiology; HIV; Incidence; Injection; San Francisco; Young adults

Mesh:

Year:  2018        PMID: 29168067      PMCID: PMC6054135          DOI: 10.1007/s10461-017-1988-y

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  54 in total

1.  Racial differences in discrimination experiences and responses among minority substance users.

Authors:  Thomas Minior; Sandro Galea; Jennifer Stuber; Jennifer Ahern; Danie Ompad
Journal:  Ethn Dis       Date:  2003       Impact factor: 1.847

Review 2.  Racial/ethnic disparities in injection drug use in large US metropolitan areas.

Authors:  Hannah Cooper; Samuel R Friedman; Barbara Tempalski; Risa Friedman; Marie Keem
Journal:  Ann Epidemiol       Date:  2005-05       Impact factor: 3.797

3.  HCV infection prevalence lower than expected among 18-40-year-old injection drug users in San Diego, CA.

Authors:  Richard S Garfein; Amanda Rondinelli; Richard F W Barnes; Jazmine Cuevas; Mitcheal Metzner; Michele Velasquez; David Rodriguez; Meredith Reilly; Jian Xing; Eyasu H Teshale
Journal:  J Urban Health       Date:  2013-06       Impact factor: 3.671

4.  Scaling-up HCV prevention and treatment interventions in rural United States-model projections for tackling an increasing epidemic.

Authors:  Hannah Fraser; Jon Zibbell; Thomas Hoerger; Susan Hariri; Claudia Vellozzi; Natasha K Martin; Alex H Kral; Matthew Hickman; John W Ward; Peter Vickerman
Journal:  Addiction       Date:  2017-09-20       Impact factor: 6.526

5.  Disclosure of sexual orientation and subsequent substance use and abuse among lesbian, gay, and bisexual youths: critical role of disclosure reactions.

Authors:  Margaret Rosario; Eric W Schrimshaw; Joyce Hunter
Journal:  Psychol Addict Behav       Date:  2009-03

6.  Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection.

Authors:  Kimberly Page; Judith A Hahn; Jennifer Evans; Stephen Shiboski; Paula Lum; Eric Delwart; Leslie Tobler; William Andrews; Lia Avanesyan; Stewart Cooper; Michael P Busch
Journal:  J Infect Dis       Date:  2009-10-15       Impact factor: 5.226

7.  Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone--Indiana, 2015.

Authors:  Caitlin Conrad; Heather M Bradley; Dita Broz; Swamy Buddha; Erika L Chapman; Romeo R Galang; Daniel Hillman; John Hon; Karen W Hoover; Monita R Patel; Andrea Perez; Philip J Peters; Pam Pontones; Jeremy C Roseberry; Michelle Sandoval; Jessica Shields; Jennifer Walthall; Dorothy Waterhouse; Paul J Weidle; Hsiu Wu; Joan M Duwve
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-01       Impact factor: 17.586

Review 8.  HIV pre-exposure prophylaxis for people who inject drugs: a review of current results and an agenda for future research.

Authors:  Daniel J Escudero; Mark N Lurie; Thomas Kerr; Chanelle J Howe; Brandon D L Marshall
Journal:  J Int AIDS Soc       Date:  2014-03-27       Impact factor: 5.396

9.  Using HIV networks to inform real time prevention interventions.

Authors:  Susan J Little; Sergei L Kosakovsky Pond; Christy M Anderson; Jason A Young; Joel O Wertheim; Sanjay R Mehta; Susanne May; Davey M Smith
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

10.  Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study.

Authors:  Evan Wood; Thomas Kerr; Brandon D L Marshall; Kathy Li; Ruth Zhang; Robert S Hogg; P Richard Harrigan; Julio S G Montaner
Journal:  BMJ       Date:  2009-04-30
View more
  3 in total

1.  Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study.

Authors:  Roman Shrestha; Frederick L Altice; Brian Sibilio; Jude Ssenyonjo; Michael M Copenhaver
Journal:  Contemp Clin Trials       Date:  2019-06-20       Impact factor: 2.226

2.  Scaling Up Hepatitis C Prevention and Treatment Interventions for Achieving Elimination in the United States: A Rural and Urban Comparison.

Authors:  Hannah Fraser; Claudia Vellozzi; Thomas J Hoerger; Jennifer L Evans; Alex H Kral; Jennifer Havens; April M Young; Jack Stone; Senad Handanagic; Susan Hariri; Carolina Barbosa; Matthew Hickman; Alyssa Leib; Natasha K Martin; Lina Nerlander; Henry F Raymond; Kimberly Page; Jon Zibbell; John W Ward; Peter Vickerman
Journal:  Am J Epidemiol       Date:  2019-08-01       Impact factor: 4.897

3.  Correlates of Transactional Sex and Violent Victimization among Men Who Inject Drugs in Los Angeles and San Francisco, California.

Authors:  Suzan M Walters; Alex H Kral; Shona Lamb; Jesse L Goldshear; Lynn Wenger; Ricky N Bluthenthal
Journal:  J Urban Health       Date:  2021-02       Impact factor: 3.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.